MODERN APPROACHES TO REHABILITATION OF PATIENTS AFTER STROKE THE THESIS
DOI:
https://doi.org/10.5281/zenodo.18439644Abstract
In recent decades, the prevalence of cerebrovascular diseases, including strokes, has been increasing, remaining a leading cause of disability in elderly individuals [4, 46]. Within a year after a stroke, approximately 30% of patients lose the ability to live independently [14, 47]. One of the priorities of healthcare in Russia is to slow the growth of disability through the development of rehabilitation, including neurorehabilitation.
References
Vakhinina N.V., Parfenov V.A., Nikitina L.Yu. Cognitive impairments after stroke and their treatment with memantine. Clinical Gerontology 2005; 11(8): 49–52.
Gusev E.I., Kamchatov P.R. Plasticity of the nervous system. Journal of Neurology and Psychiatry named after S.S. Korsakov 2004; 3: 73–78.
Ilyasova F.N., Levin O.S. The effect of glucose-lowering therapy on the dynamics of cognitive impairment in type 2 diabetes in the early recovery period after ischemic stroke. Zemsky Doctor 2015; 3(27): 19–22.
Karpova E.N., Muravyev K.A., Muravyeva V.N., Karpov S.M., Shevchenko P.P., Vyshlova I.A., Dolgova I.N., Khatueva A.A. Epidemiology and risk factors of ischemic stroke. Modern Problems of Science and Education 2015; 4: 441–450.
Kovalchuk V.V. Effect of Mexidol on neurological deficit, social adaptation, and neglect/rejection syndromes in post-stroke patients. Journal of Neurology and Psychiatry named after S.S. Korsakov 2011; 111(12–2): 52–57.
Kosivtsova O.V. Management of patients in the post-stroke recovery period. Neurology, Neuropsychiatry, Psychosomatics 2014; 4: 101–105.
Kotov S.V., Isakova E.V., Chataeva G.S., Prokhorova N.V. Acatinol Memantine in the treatment of patients with ischemic stroke. Psychiatry and Psychopharmacotherapy 2005; 7(6): 343–345.
Kryzhanovsky G.N. Plasticity in nervous system pathology. Journal of Neurology and Psychiatry named after S.S. Korsakov 2001; 101(2): 4–7.
Levin O.S., Vasenina E.E. Application of Acatinol Memantine in clinical practice. Modern Therapy in Psychiatry and Neurology 2015; 1: 24–33.
Luria A.R. Higher cortical functions of the human brain and their disorders in focal brain lesions. 3rd ed. Moscow: Academic Project, 2000; 512 p.
Makotrova T.A., Trusova N.A., Shrader N.I., Levin O.S. Neuroprotective potential of Acatinol Memantine in ischemic stroke. Journal of Neurology and Psychiatry named after S.S. Korsakov 2013; 113(7–2): 82–85.
Pustokhanova L.V., Kulesh A.A., Morozova E.M. Features of cognitive and affective disorders in the early recovery period after ischemic stroke. Family Health – 21st Century 2010; 2. Available at: http://elibrary.ru/contents.asp?issueid=862398 (accessed 21.22.2016).
Rumyantseva S.A., Orlova A.S., Orlov V.A., Silin S.V. Early diagnosis and prevention of post-stroke depression. Modern Medical Science 2011; 1: 104–115.
Rumyantseva S.A., Silina E.V., Orlova A.S., Bolevich S.B. Assessment of rehabilitation potential in comorbid stroke patients. Bulletin of Restorative Medicine 2014; 3: 91–92.
Selyavko L.E., Tsvetkova L.S. Device for paired-card exercises in memory restoration and preventive training for neurological patients. In: Selected Issues of Neurorehabilitation: Proceedings of the VIII International Congress “Neurorehabilitation-2016” (Moscow, June 8–10, 2016). Moscow: Union of Rehabilitation Specialists of Russia 2016: 328–330.
Khatkova S.E. Use of Acatinol Memantine in post-stroke dementia. Clinical Gerontology 2008; 14(8): 19–21.
